April 2023 - Volume 77 - Issue 4 : Hepatology

Secondary Logo

Journal Logo

April 2023 - Volume 77 - Issue 4
pp: 1067-1459,E62-E83

Immune-Mediated Diseases

Budesonide as first-line treatment in patients with autoimmune hepatitis seems inferior to standard predniso(lo)ne administration

Díaz-González, Álvaro; Hernández-Guerra, Manuel; Pérez-Medrano, Indhira; More

Hepatology. 77(4):1095-1105, April 2023.

Liver Cancer

Malignant progression of liver cancer progenitors requires lysine acetyltransferase 7–acetylated and cytoplasm‐translocated G protein GαS

Zhou, Ye; Jia, Kaiwei; Wang, Suyuan; More

Hepatology. 77(4):1106-1121, April 2023.

Eliminating METTL1‐mediated accumulation of PMN‐MDSCs prevents hepatocellular carcinoma recurrence after radiofrequency ablation

Zeng, Xuezhen; Liao, Guanrui; Li, Shumin; More

Hepatology. 77(4):1122-1138, April 2023.

Liver Pathobiology

Probiotic‐derived nanoparticles inhibit ALD through intestinal miR194 suppression and subsequent FXR activation

Jiang, Mengwei; Li, Fengyuan; Liu, Yunhuan; More

Hepatology. 77(4):1164-1180, April 2023.

Liver Failure/Cirrhosis/Portal Hypertension

ALK1 controls hepatic vessel formation, angiodiversity, and angiocrine functions in hereditary hemorrhagic telangiectasia of the liver

Schmid, Christian David; Olsavszky, Victor; Reinhart, Manuel; More

Hepatology. 77(4):1211-1227, April 2023.

Janus kinase 2 inhibition by pacritinib as potential therapeutic target for liver fibrosis

Torres, Sandra; Ortiz, Cristina; Bachtler, Nadine; More

Hepatology. 77(4):1228-1240, April 2023.

Multicentered study of patient outcomes after declined for early liver transplantation in severe alcohol-associated hepatitis

Hsu, Christine C.; Dodge, Jennifer L.; Weinberg, Ethan; More

Hepatology. 77(4):1253-1262, April 2023.


Serum FGF19 predicts outcomes of Kasai portoenterostomy in biliary atresia

Nyholm, Iiris; Hukkinen, Maria; Pihlajoki, Marjut; More

Hepatology. 77(4):1263-1273, April 2023.


Apolipoprotein F is reduced in humans with steatosis and controls plasma triglyceride‐rich lipoprotein metabolism

Deprince, Audrey; Hennuyer, Nathalie; Kooijman, Sander; More

Hepatology. 77(4):1287-1302, April 2023.

Essential lipid autacoids rewire mitochondrial energy efficiency in metabolic dysfunction‐associated fatty liver disease

López‐Vicario, Cristina; Sebastián, David; Casulleras, Mireia; More

Hepatology. 77(4):1303-1318, April 2023.

RIPK3 dampens mitochondrial bioenergetics and lipid droplet dynamics in metabolic liver disease

Afonso, Marta B.; Islam, Tawhidul; Magusto, Julie; More

Hepatology. 77(4):1319-1334, April 2023.

Viral Hepatitis

Mitochondrial stress in advanced fibrosis and cirrhosis associated with chronic hepatitis B, chronic hepatitis C, or nonalcoholic steatohepatitis

Loureiro, Dimitri; Tout, Issam; Narguet, Stéphanie; More

Hepatology. 77(4):1348-1365, April 2023.

A multidisciplinary approach to the diagnosis and management of Wilson disease: Executive summary of the 2022 Practice Guidance on Wilson disease from the American Association for the Study of Liver Diseases

Schilsky, Michael L.; Roberts, Eve A.; Bronstein, Jeff M.; More

Hepatology. 77(4):1428-1455, April 2023.


van Kleef, Laurens A.; de Knegt, Robert J.; Brouwer, Willem Pieter

Hepatology. 77(4):E69-E70, April 2023.


Vizzutti, Francesco; Celsa, Ciro; Battaglia, Salvatore; More

Hepatology. 77(4):E76-E77, April 2023.